What happened: A court ruling requires patients to see a healthcare provider in person to obtain the abortion pill mifepristone, blocking access by mail. This decision is currently being appealed.
Why it matters:
- Limits remote access to abortion medication, affecting patient convenience and privacy.
- Impacts abortion providers and patients across the US, particularly in areas with fewer clinics.
MNN Take: The ruling reverses previous allowances for mailing abortion pills, requiring physical visits to healthcare providers, which may complicate access for many seeking abortion services.
Sources: NYTimes US